Population: Fragile population

Individuals who are more vulnerable to poor health outcomes due to factors like chronic illness, weakened immune systems, disabilities or socioeconomic disadvantages

Perrotta

Italy
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Fragile population
  • Hospital wide
  • Emergency department
  • Infectious diseases unit
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab
  • Bamlanivimab/ Etesevimab

Gentile

Italy
|
2023-2023
  • Adults
  • General population
  • Elderly
  • Fragile population
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Monoclonal antibodies
  • Sotrovimab

Drysdale

United Kingdom
|
2022-2022
  • Adults
  • Elderly
  • Fragile population
  • Primary care
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Monoclonal antibodies
  • Sotrovimab
  • Molnupiravir

Rotundo

Italy
|
2022-2023
  • Adults
  • Fragile population
  • Immunocompromised host
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Monoclonal antibodies
  • Sotrovimab
  • Molnupiravir
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Nguyen

France
|
2021-2022
  • Adults
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Tixagevimab/Cilgavimab

Pinargote-Celorio

Spain
|
2022-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Monoclonal antibodies
  • Sotrovimab

Colaneri

Italy
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Svartstein

Denmark
|
2022-2022
  • Adults
  • Elderly
  • Fragile population
  • People at high risk of STIs
  • Men who have sex with men
  • People living with HIV
  • Hospital wide
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox

Villamarin

Spain
|
2022-2022
  • Adults
  • Fragile population
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Molnupiravir

Wildi

Argentina Australia Brazil Germany Hong Kong Italy Japan South Africa Spain United States of America Ireland
|
2020
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19

Schlosser

Germany
|
2022
  • Fragile population
  • Immunocompromised host
  • SARS-CoV-2
  • Post-COVID-19

MonVIP

France
|
2023
  • Adults
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • People living with HIV
  • PrEP users
  • Hospital wide
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox